Abstract:
The development of genetic technologies, nano-technologies and technologies related to artificial intelligence have provoked discussion about the different uses to which they may be put; namely, their potential for therapeutic and non-therapeutic use. Resisting claims that individuals should be free to use these technologies as they see fit to alter their own physical, psychological and intellectual capacities, lifespan and morphologies or those of their existing or future children, some authors contend that both ethical and regulatory limits should be placed on this exercise of free choice.1 A number of academics have suggested that the therapy/enhancement distinction can perform both moral and regulatory work in assisting us with resolving the tricky issue of which uses of these technologies to permit and which to discourage or ban.
